Y Intercept (Hong Kong) LTD Castle Biosciences Inc Transaction History
Y Intercept (Hong Kong) LTD
- $1.44 Billion
- Q4 2024
A detailed history of Y Intercept (Hong Kong) LTD transactions in Castle Biosciences Inc stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 21,839 shares of CSTL stock, worth $473,469. This represents 0.04% of its overall portfolio holdings.
Number of Shares
21,839
Previous 24,206
9.78%
Holding current value
$473,469
Previous $690,000
15.65%
% of portfolio
0.04%
Previous 0.04%
Shares
5 transactions
Others Institutions Holding CSTL
# of Institutions
210Shares Held
26.6MCall Options Held
128KPut Options Held
35.4K-
Black Rock Inc. New York, NY3.04MShares$66 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.83MShares$39.7 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.8MShares$38.9 Million0.24% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.44MShares$31.1 Million0.02% of portfolio
-
Dimensional Fund Advisors LP Austin, TX999KShares$21.7 Million0.01% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $570M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...